Wellington Management Group LLP Gilead Sciences, Inc. Transaction History

Wellington Management Group LLP

$548 Billion
Q2 2024

A detailed history of Wellington Management Group LLP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 22,935,083 shares of GILD stock, worth $1.92 Billion. This represents 0.29% of its overall portfolio holdings.

Number of Shares

22,935,083

Previous 20,567,752 11.51%

Holding current value

$1.92 Billion

Previous $1.51 Billion 4.45%

% of portfolio

0.29%

Previous 0.27%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $149 Million - $173 Million	2,367,331 Added 11.51%	22,935,083 $1.57 Billion
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $1.47 Billion - $1.8 Billion	20,567,752 New	20,567,752 $1.51 Billion
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $1.37 Billion - $1.55 Billion	18,630,134 New	18,630,134 $1.51 Billion
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $26.8 Million - $29.2 Million	-361,918 Reduced 2.17%	16,279,584 $1.22 Billion
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $953 Million - $1.09 Billion	12,539,306 Added 305.67%	16,641,502 $1.28 Billion
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $85.3 Million - $97.1 Million	1,102,961 Added 36.77%	4,102,196 $340 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $168 Million - $242 Million	2,703,726 Added 914.94%	2,999,235 $257 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $1.94 Million - $2.22 Million	-32,650 Reduced 9.95%	295,509 $18.2 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $23.2 Million - $26.1 Million	-401,336 Reduced 55.02%	328,159 $20.3 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.35 Million - $1.7 Million	23,391 Added 3.31%	729,495 $43.4 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $26.9 Million - $30.6 Million	415,317 Added 142.83%	706,104 $51.3 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $896,960 - $967,720	-13,251 Reduced 4.36%	290,787 $20.3 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $13.5 Million - $14.7 Million	-212,419 Reduced 41.13%	304,038 $20.9 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $13.3 Million - $15.2 Million	-222,136 Reduced 30.08%	516,457 $33.4 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $3.73 Million - $4.25 Million	-65,816 Reduced 8.18%	738,593 $43 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $8.93 Million - $11.2 Million	-143,824 Reduced 15.17%	804,409 $50.8 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $87.2 Million - $101 Million	-1,205,686 Reduced 55.98%	948,233 $73 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $130 Million - $166 Million	-2,070,421 Reduced 49.01%	2,153,919 $161 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $260 Million - $286 Million	4,224,340 New	4,224,340 $274 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Gilead Sciences, Inc. Transaction History